Treatments for ANCA Vasculitis

Here’s the quick and easy breakdown:

Rituximab has a far better rate of maintaining remission than methotrexate and azathioprine. The relapse rate in Azathioprine is 29% whereas Rituximab is only 5%. Azathioprine and Methotrexate have similar induction and relapse rates. With CellCept being the lowest rate of remission among the four options.

As always I can DM you with links to the studies I used as well as the American College of Rheumatology’s Official Guidelines.